Vertex Receives CHMP Opinion For KAFTRIO In Combination With Ivacaftor For Children With Cystic Fibrosis Ages 2 Through 5

Benzinga · 09/15/2023 12:53

-If approved, more than 1,200 children would be newly eligible for a medicine that could treat the underlying cause of their disease-